CRAGG, MARK,GLENNIE, MARTIN,ROGHANIAN, ALI,BEERS, STEPHEN,JOHNSON, PETER,LIM, SEAN,FRENDEUS, BJOERN,TEIGE, INGRID
申请号:
CA2808744
公开号:
CA2808744A1
申请日:
2011.08.19
申请国别(地区):
CA
年份:
2012
代理人:
摘要:
The invention provides a method of treating a patient having target cells that express FcyRIIb, the method comprising administering (i) an antibody molecule that specifically binds a surface antigen of the target cell, which antibody molecule has an Fc domain capable of binding FcyRIIb; in combination with (ii) an agent that prevents or reduces binding between the Fc domain of the antibody molecule and FcyRIIb; characterized in that the patient is selected on the basis that their target cells express an elevated level of FcyRIIb.